Bimzelx (bimekizumab)

pCPA File Number: 21821
Negotiation Status:
Active Negotiation
Indication(s):
psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
UCB Canada Inc.
CADTH Project Number:
SR0698
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable